Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing
1 other identifier
observational
305
1 country
1
Brief Summary
The purpose of this study is to determine the prevalence and treatment rates of T. vaginalis, C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy testing in the Magee-Womens Hospital outpatient clinic using a non-invasive urine STD test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2009
CompletedFirst Posted
Study publicly available on registry
September 17, 2009
CompletedStudy Start
First participant enrolled
November 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedMay 18, 2016
May 1, 2016
5 months
September 16, 2009
May 17, 2016
Conditions
Keywords
Study Arms (2)
Women seeking emergency contraception
Women seeking emergency contraception
Women seeking urine pregnancy testing
Women seeking urine pregnancy testing
Eligibility Criteria
Females at least age 15 at time of enrollment who are presenting at Magee-Womens Hospital for emergency contraception or urine pregnancy testing
You may qualify if:
- Females at least age 15 at time of enrollment who are presenting at Magee-Womens Hospital for emergency contraception or urine pregnancy testing.
- Ability to provide written informed consent.
You may not qualify if:
- Diagnosis and/or treatment for an STD within 4 weeks of enrollment in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Gen-Probe, Incorporatedcollaborator
Study Sites (1)
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, 15213, United States
Biospecimen
Any left over urine may be frozen for future use on infections in women
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harold C Wiesenfeld, MD, CM
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Division of Gynecologic Specialties & Division of Reproductive Infectious Diseases and Immunology
Study Record Dates
First Submitted
September 16, 2009
First Posted
September 17, 2009
Study Start
November 1, 2009
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
May 18, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share